These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Methylphenidate-induced "Moving Ear Syndrome" in a child with ADHD responding favorably to add-on propranolol. Naguy A; Alrashidi F; Elsori DH Asia Pac Psychiatry; 2019 Mar; 11(1):e12347. PubMed ID: 30474193 [No Abstract] [Full Text] [Related]
12. Transdermal methylphenidate (Daytrana) for ADHD. Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850 [No Abstract] [Full Text] [Related]
13. A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate. Northup J; Jones K; Broussard C; DiGiovanni G; Herring M; Fusilier I; Hanchey A J Appl Behav Anal; 1997; 30(1):121-5. PubMed ID: 9157096 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of methylphenidate. Daniels SR J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283 [No Abstract] [Full Text] [Related]
15. Methylphenidate and chromosome damage. Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105 [No Abstract] [Full Text] [Related]
16. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'. Olders H J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567 [No Abstract] [Full Text] [Related]
17. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient. Pérez CA; Garcia SS; Yu RD J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198 [No Abstract] [Full Text] [Related]
18. [Prevention of tardive dyskinesia caused by neuroleptic therapy]. Perényi A Orv Hetil; 1981 Jul; 122(27):1627-30. PubMed ID: 6117046 [No Abstract] [Full Text] [Related]